Literature DB >> 26162273

[Cross-sectional imaging evaluation of renal masses].

P Nuhn1, A Sterzik, C G Stief, M Staehler, M D'Anastasi.   

Abstract

Cross-sectional imaging modalities including multidetector computed tomography (MDCT) and magnetic resonance imaging (MRI) are the diagnostic standard in detection, characterization, and staging of renal masses due to their high sensitivity and specificity. Currently, most renal masses are incidentally diagnosed by imaging for other medical reasons. Recent developments have improved image acquisition with high resolution, while simultaneously reducing radiation dose. CT imaging is the most accessible cross-sectional imaging method and is, therefore, the standard technique. MRI is indicated in patients who are allergic to intravenous CT contrast medium, in patients with renal insufficiency, or in younger patients. Further characterization of renal masses is possible with functional imaging including dual energy CT, perfusion CT, or diffusion-weighted MRI. Contrast-enhanced ultrasound allows detection of even subtle enhancement in hypovascular lesions with high sensitivity and can add valuable information to CT and MRI studies.

Entities:  

Mesh:

Year:  2015        PMID: 26162273     DOI: 10.1007/s00120-015-3866-4

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  35 in total

Review 1.  Imaging of advanced renal cell carcinoma.

Authors:  Ullrich G Mueller-Lisse; Ulrike L Mueller-Lisse
Journal:  World J Urol       Date:  2010-05-11       Impact factor: 4.226

Review 2.  Functional renal imaging: nonvascular renal disease.

Authors:  H J Michaely; K A Herrmann; K Nael; N Oesingmann; M F Reiser; S O Schoenberg
Journal:  Abdom Imaging       Date:  2006-01-30

3.  Papillary renal cell carcinoma within a renal oncocytoma: case report of an incidental finding of a tumour within a tumour.

Authors:  Corwyn Rowsell; Neil Fleshner; Paula Marrano; Jeremy Squire; Andrew Evans
Journal:  J Clin Pathol       Date:  2007-04       Impact factor: 3.411

4.  Angiomyolipoma with minimal fat: can it be differentiated from clear cell renal cell carcinoma by using standard MR techniques?

Authors:  Nicole Hindman; Long Ngo; Elizabeth M Genega; Jonathan Melamed; Jesse Wei; Julia M Braza; Neil M Rofsky; Ivan Pedrosa
Journal:  Radiology       Date:  2012-09-25       Impact factor: 11.105

Review 5.  Increased incidence of serendipitously discovered renal cell carcinoma.

Authors:  M Jayson; H Sanders
Journal:  Urology       Date:  1998-02       Impact factor: 2.649

6.  Precise segmental renal artery clamping under the guidance of dual-source computed tomography angiography during laparoscopic partial nephrectomy.

Authors:  Pengfei Shao; Lijun Tang; Pu Li; Yi Xu; Chao Qin; Qiang Cao; Xiaobing Ju; Xiaoxin Meng; Qiang Lv; Jie Li; Wei Zhang; Changjun Yin
Journal:  Eur Urol       Date:  2012-06-07       Impact factor: 20.096

Review 7.  Papillary renal cell carcinoma: radiologic-pathologic correlation and spectrum of disease.

Authors:  Raghunandan Vikram; Chaan S Ng; Pheroze Tamboli; Nizar M Tannir; Eric Jonasch; Surena F Matin; Christopher G Wood; Carl M Sandler
Journal:  Radiographics       Date:  2009 May-Jun       Impact factor: 5.333

Review 8.  Contrast-enhanced ultrasound for diagnosis of prostate cancer and kidney lesions.

Authors:  Michael Mitterberger; Alexandre Pelzer; Daniela Colleselli; Georg Bartsch; Hannes Strasser; Leo Pallwein; Friedrich Aigner; Johann Gradl; Ferdinand Frauscher
Journal:  Eur J Radiol       Date:  2007-09-18       Impact factor: 3.528

9.  Renal oncocytoma: CT features cannot reliably distinguish oncocytoma from other renal neoplasms.

Authors:  S Choudhary; A Rajesh; N J Mayer; K A Mulcahy; A Haroon
Journal:  Clin Radiol       Date:  2009-03-09       Impact factor: 2.350

10.  Combined diffusion-weighted, blood oxygen level-dependent, and dynamic contrast-enhanced MRI for characterization and differentiation of renal cell carcinoma.

Authors:  Mike Notohamiprodjo; Michael Staehler; Nicole Steiner; Felix Schwab; Steven P Sourbron; Henrik J Michaely; Andreas D Helck; Maximilian F Reiser; Konstantin Nikolaou
Journal:  Acad Radiol       Date:  2013-06       Impact factor: 3.173

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.